A detailed history of Voya Investment Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 386,699 shares of EXEL stock, worth $12.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
386,699
Previous 496,955 22.19%
Holding current value
$12.9 Million
Previous $11.2 Million 10.14%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.96 - $27.6 $2.42 Million - $3.04 Million
-110,256 Reduced 22.19%
386,699 $10 Million
Q2 2024

Dec 03, 2024

BUY
$20.34 - $23.73 $2.24 Million - $2.62 Million
110,256 Added 28.51%
496,955 $11.2 Million
Q2 2024

Aug 14, 2024

BUY
$20.34 - $23.73 $251,219 - $293,089
12,351 Added 2.55%
496,955 $11.2 Million
Q1 2024

Dec 06, 2024

BUY
$20.17 - $23.93 $1.97 Million - $2.34 Million
97,905 Added 25.32%
484,604 $11.5 Million
Q1 2024

May 15, 2024

SELL
$20.17 - $23.93 $1.12 Million - $1.33 Million
-55,617 Reduced 10.3%
484,604 $11.5 Million
Q4 2023

Feb 14, 2024

BUY
$19.25 - $24.13 $2.95 Million - $3.69 Million
153,005 Added 39.51%
540,221 $13 Million
Q3 2023

Nov 14, 2023

SELL
$19.04 - $22.74 $14,565 - $17,396
-765 Reduced 0.2%
387,216 $8.46 Million
Q2 2023

Aug 14, 2023

SELL
$18.17 - $20.48 $143,724 - $161,996
-7,910 Reduced 2.0%
387,981 $7.41 Million
Q1 2023

May 15, 2023

BUY
$16.3 - $19.41 $1.35 Million - $1.61 Million
82,900 Added 26.49%
395,891 $7.68 Million
Q4 2022

Feb 14, 2023

SELL
$14.96 - $17.39 $575,286 - $668,732
-38,455 Reduced 10.94%
312,991 $5.02 Million
Q3 2022

Mar 03, 2023

BUY
$15.68 - $22.27 $602,974 - $856,392
38,455 Added 12.29%
351,446 $5.51 Million
Q3 2022

Nov 14, 2022

BUY
$15.68 - $22.27 $1.18 Million - $1.67 Million
75,088 Added 27.17%
351,446 $5.51 Million
Q2 2022

Aug 15, 2022

BUY
$17.44 - $23.16 $75,445 - $100,190
4,326 Added 1.59%
276,358 $5.75 Million
Q1 2022

May 16, 2022

SELL
$17.03 - $22.67 $106,846 - $142,231
-6,274 Reduced 2.25%
272,032 $6.17 Million
Q4 2021

Feb 14, 2022

BUY
$15.84 - $21.88 $711,025 - $982,149
44,888 Added 19.23%
278,306 $5.09 Million
Q3 2021

Nov 15, 2021

SELL
$16.3 - $21.14 $101,027 - $131,025
-6,198 Reduced 2.59%
233,418 $4.94 Million
Q2 2021

Aug 16, 2021

BUY
$17.95 - $25.56 $843,039 - $1.2 Million
46,966 Added 24.38%
239,616 $4.37 Million
Q1 2021

May 17, 2021

SELL
$20.53 - $25.22 $133,465 - $163,955
-6,501 Reduced 3.26%
192,650 $4.35 Million
Q4 2020

Feb 16, 2021

SELL
$18.39 - $24.8 $125,474 - $169,210
-6,823 Reduced 3.31%
199,151 $4 Million
Q3 2020

Nov 16, 2020

SELL
$20.67 - $26.94 $146,674 - $191,166
-7,096 Reduced 3.33%
205,974 $5.04 Million
Q2 2020

Aug 14, 2020

SELL
$16.46 - $27.42 $109,640 - $182,644
-6,661 Reduced 3.03%
213,070 $5.06 Million
Q1 2020

May 15, 2020

SELL
$14.46 - $21.8 $60,703 - $91,516
-4,198 Reduced 1.87%
219,731 $3.78 Million
Q4 2019

Feb 14, 2020

SELL
$15.15 - $18.89 $899,803 - $1.12 Million
-59,393 Reduced 20.96%
223,929 $3.95 Million
Q3 2019

Nov 14, 2019

BUY
$17.68 - $22.65 $151,181 - $193,680
8,551 Added 3.11%
283,322 $5.01 Million
Q2 2019

Aug 14, 2019

BUY
$18.93 - $24.75 $108,052 - $141,273
5,708 Added 2.12%
274,771 $5.87 Million
Q1 2019

May 15, 2019

SELL
$19.6 - $24.76 $426,986 - $539,396
-21,785 Reduced 7.49%
269,063 $6.4 Million
Q4 2018

Feb 14, 2019

BUY
$13.65 - $21.8 $520,815 - $831,779
38,155 Added 15.1%
290,848 $5.72 Million
Q3 2018

Nov 14, 2018

SELL
$15.87 - $22.4 $55.4 Million - $78.1 Million
-3,488,542 Reduced 93.25%
252,693 $4.48 Million
Q2 2018

Aug 14, 2018

BUY
$18.56 - $22.45 $18.8 Million - $22.7 Million
1,013,121 Added 37.14%
3,741,235 $80.5 Million
Q1 2018

May 15, 2018

BUY
$22.15 - $31.89 $3.19 Million - $4.6 Million
144,144 Added 5.58%
2,728,114 $60.4 Million
Q4 2017

Feb 14, 2018

BUY
$24.23 - $30.93 $23.9 Million - $30.6 Million
988,260 Added 61.93%
2,583,970 $78.6 Million
Q3 2017

Nov 14, 2017

BUY
$23.35 - $29.24 $37.3 Million - $46.7 Million
1,595,710
1,595,710 $38.7 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.